… Less than half of patients with major depressive disorder (MDD) respond to their first … of
selective serotonin reuptake inhibitors (SSRIs) remains poor, and there is no reliable method of …

… Mothers were considered to be symptomatically depressed with a total HAM-D score > 8 (69). …
serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI). …

… serotonin reuptake inhibitors (SSRIs), as part of the routine treatment of stroke patients
regardless of the presence of depressive … the safety of antidepressant treatment in stroke patients. …

… Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed agents
in this condition and, although generally safe, tolerability issues cannot be overlooked. …

… to low compliance in elderly depression patients in China, it is urgent to assess the safety of
6 … Depression and your heart link between depression, coronary heart disease mental health …

… In this study, few AEs were reported in the EA group, indicating that EA shows potential as
a safe therapy for depression treatment and supports the findings of one systematic review, …

… In the review on pain and comorbid depression that we included,31 nine of the 14 included
… Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as …

… groups – selective serotonin reuptake inhibitors (fluvoxamine, … safety in cardiac patients
according to the literature [4–6, 11]. … In this study, selective serotonin reuptake inhibitors had the …

… serotonin reuptake inhibitors (SSRIs) and selective serotonin … placebo among very severely
depressed patients – rather than … MAOIs and having a superior tolerability and safety profile. …

… depression are important aspects of clinical stroke care. Pharmacotherapy is the first-line
treatment of PSD, with selective serotonin reuptake inhibitors … of coronary artery disease events, …